Novo Nordisk to bring down insulin prices by up to 75% (NYSE:NVO)

Novo Nordisk (NVO) plans to slash the U.S. list prices of several insulin products by up to 75%, The WSJ reported Tuesday, following a similar move by Lilly (LLY). Read the full story here.

Related Keywords

Indiana ,United States ,Denmark ,Danish ,Steve Albers ,Novo Nordisk ,New Nordisk ,Wall Street Journal ,Eli Lilly ,